Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88215704 | FILING DATE | 12/04/2018 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | BIACHE, AUBREY ANNE |
L.O. ASSIGNED | N50-NOT FOUND |
PUB INFORMATION |
|||
RUN DATE | 11/10/2020 | ||
PUB DATE | 04/23/2019 | ||
STATUS | 732-THIRD EXTENSION - GRANTED | ||
STATUS DATE | 11/09/2020 | ||
LITERAL MARK ELEMENT | DAURISMO | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | NO |
LITERAL MARK ELEMENT | DAURISMO |
MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 20-OWNER AT PUBLICATION |
NAME | Pfizer Inc. |
ADDRESS | 235 East 42nd Street New York, NY 10017 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use |
INTERNATIONAL CLASS | 044 |
DESCRIPTION TEXT | Providing medical information in the field of oncological diseases and disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
DESCRIPTION OF MARK | The mark consists of the word "DAURISMO" with a stylized circle surrounding the letters "SMO". |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
11/10/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 026 |
11/09/2020 | EX3G | S | EXTENSION 3 GRANTED | 025 |
11/08/2020 | EXT3 | S | EXTENSION 3 FILED | 024 |
11/08/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 023 |
06/05/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 022 |
06/03/2020 | EX2G | S | EXTENSION 2 GRANTED | 021 |
06/03/2020 | EXT2 | S | EXTENSION 2 FILED | 020 |
06/03/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 019 |
12/17/2019 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 018 |
12/16/2019 | ALIE | A | ASSIGNED TO LIE | 017 |
12/13/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 016 |
12/11/2019 | EX1G | S | EXTENSION 1 GRANTED | 015 |
12/11/2019 | EXT1 | S | EXTENSION 1 FILED | 014 |
12/11/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 013 |
12/11/2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 012 |
12/11/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 011 |
11/13/2019 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 010 |
06/18/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 009 |
04/23/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 008 |
04/23/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 007 |
04/03/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 006 |
03/13/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 005 |
03/05/2019 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
12/22/2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
12/21/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
12/07/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Richard A. Friedman |
CORRESPONDENCE ADDRESS | Richard A. Friedman PFIZER INC. 235 EAST 42ND STREET NEW YORK NY 10017 |
DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Pfizer Inc. |
ADDRESS | 235 East 42nd Street New York, NY 10017 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |